ArticleRegulatory toxicology and pharmacology : RTPPublished
FIH dose selection beyond MABEL: Optimizing phase 1 clinical trial starting dose whilst protecting patient safety
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Regulatory toxicology and pharmacology : RTP
- Published
- Topic
- Clinical care
- Subject terms
- Animals; Humans; Immunologic Factors; Risk Assessment; Dose-Response Relationship, Drug; Models, Biological; Clinical Trials, Phase I as Topic; Patient Safety; Drug Development; Immunomodulating Agents
- PubMed ID
- 41621794
- Added to directory
- Source checked